Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
Clinical trial NCT06142318 · UNKNOWN
Trial details
- NCT number
- NCT06142318
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2025-01-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.